It's been just over three years since I got married, and I remember thinking (amid the nearly debilitating fear that we would run out of alcohol at our mountain cabin wedding and thus trap our families in a scene from The Shining) that it would be wonderful to finally be free forever from the intrigue and confusion of dating.

You can't fault the optimism.

Now, through the lens of hindsight, I realize that I should have known that dating and even cohabitating were only warm-ups for the big dance.

HONG KONG, April 25 /PRNewswire/ --

- First NetDragon Credit Card Issued in China

NetDragon Websoft Inc. ("NetDragon" or the "Company", with its subsidiary collectively the "Group"; stock code: 8288.HK) and Industrial and Commercial Bank of China ("ICBC") today announced the official issuance of the "Peony NetDragon Credit Card" at all branches of ICBC across the PRC. The signing ceremony is being held this morning at the Peony Credit Card Centre at the ICBC headquarters in Beijing. The hosts of the signing ceremony are Mr. Liu Luyuan, Executive Director and Chief Executive Officer of NetDragon, and Mr. Li Weiping, President of ICBC's Peony Card Centre.

LONDON, April 25 /PRNewswire/ -- Tony Woodley, Joint General Secretary of Unite, will address a mass meeting of workers at INEOS in Grangemouth today ahead of a two day strike planned for Sunday 27th and Monday 28th April.

Tony Woodley is attending the plant to make clear Unite's, the UK's largest trade union, steadfast support and solidarity for the Grangemouth workers as they prepare to take strike action to defend their pensions. Unite has 1,200 members at the plant involved in the dispute.

SINGAPORE, April 25 /PRNewswire/ -- Energenics Pte Ltd, a wholly owned subsidiary of Energenics Holdings Pte Ltd, announced today it has agreed to appoint Creuros Srl as the Italian distributor for the company's Enercat fuel borne catalyst.

Ronen Hazarika, Managing Director noted: "The partnership with Creuros permits us to extend our reach into Italy through Creuros' field operations and also to tap into Creuros' expanding customer base in Italy. We look forward to a long and mutually beneficial distributor relationship with Creuros."

"The signing of our first European distributor heralds our launch into Europe where we will expend huge resource in becoming the most competitive fuel borne nanocatalyst of choice. "

HOUSTON, Texas, April 25 /PRNewswire/ --

- Flashcard Freeware Makes Learning Easy and Fun

LearnLift announces a new release of MemoryLifter, a popular flashcard freeware. The study software is based on the scientific boxcard method developed by Sebastian Leitner, a pioneer in the field of learning. MemoryLifter employs controlled repetition, timed spacing, and mnemonic elements (like images and audio) to greatly speed up the memorization process and "lift" the information into the long-term memory.

LONDON, April 25 /PRNewswire/ -- The Vyouz network is a pioneering and innovative team of individuals developing environmentally-sensible working websites. With over 200 domains and 30 green brands to its credit Vyouz is set to become one of the biggest names in the battle against climate change.

http://www.vskips.co.uk and http://www.vdumpsters.com are some of the fastest growing recycling sites in the UK and USA and are part of the portfolio of eco brands owned by Vyouz and as such are examples of the amazing pace at which virtual ideas can take off, proving people want to do more to help the environment.

With over 12,000 active members using vskips alone it gives you an idea of the popularity of such simple ideas.

ROME, April 25 /PRNewswire/ -- Creuros Srl, Italian distributor for Oxonica's Envirox fuel additive technology would like to clarify statements made in Oxonica's press on 18 February 2008 and repeated in its recent 2007 preliminary results presentation on 17th March 2008.

The statements made in the press release in relation to test results in Italian trials of Envirox, should be clarified.

Oxonica claimed in its Press Release on 18 February 2008:

"In addition to the successful Stagecoach validation trial, Envirox(TM) has achieved further positive test results and has made significant commercial progress in mainland Europe and Russia: A recently completed bus trial in Italy demonstrated fuel savings of 4.8% after 3 months and 10.6% after 6 months."

LA JOLLA, California, April 25 /PRNewswire/ --

Duska Therapeutics, Inc. (OTC Bulletin Board: DSKA) ("Duska" or the "Company"), a biotechnology company developing medical products based on adenosine 5'-triphosphate (ATP) and P2 receptor-related technologies, announced today that the Company's management and clinical and regulatory consultants met on April 16 with members of the United States Food and Drug Administration (FDA) Division of Cardiovascular and Renal Products. The purpose of the meeting was to discuss the appropriate regulatory pathway for filing a marketing application of ATPace(TM) as an antiarrhythmic drug for the acute termination of paroxysmal supraventricular tachycardia (PSVT).

LONDON, April 25 /PRNewswire/ --

- Award-Winning Online Optician Gets the Hosting and Scalable Platform to Support Exponential Growth Through Innovative Start-Up Program

Glasses Direct has signed up as a member and customer of the hosting offer in the Sun Start-Up Essentials program in the UK. As part of the program, the online glasses retailer has outsourced the management of its hosted platform to NTT Europe Online.

Advance directives, or living wills, may not effectively honor end-of-life wishes because life-sustaining treatment preferences often change without people being aware of the changes, according to a new study co-authored by UC Irvine researchers Peter Ditto and Elizabeth Loftus.

False memories can play a significant role in the discrepancy between an individual's true preferences for end-of-life treatment and what is instructed in their living will. Life-sustaining treatment preferences often change as people age or experience new health problems, and advance directive forms typically remind people of their right to update their directives if their wishes change.